Cardiovascular-kidney-metabolic syndrome
MONDO:0976301A syndrome characterized by multiorgan dysfunction and a high rate of adverse cardiovascular outcomes arising from the interconnection between cardiovascular disease, chronic kidney disease, and metabolic risk factors associated with diabetes and obesity.
15 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Could adding a second diabetes drug early save lives?
Knowledge-focused CompletedThis study analyzed health records of over 118,000 adults with obesity, type 2 diabetes, and related heart, kidney, and liver conditions. Researchers compared people who added a second type of diabetes drug (GLP-1 or SGLT2) early to those who did not. The goal was to see if early…
Sponsor: Chung Shan Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Could adding a second diabetes drug early save lives?
Knowledge-focused CompletedThis study analyzed health records from over 450,000 adults with obesity and type 2 diabetes to see if adding a GLP-1 or SGLT2 drug early improves survival and kidney health. Researchers compared those who added the other drug class within 90 days to those who added a different d…
Sponsor: Chung Shan Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Food as medicine: study tests grocery vouchers for High-Risk patients
Knowledge-focused CompletedThis study tested whether giving Medicaid patients with stage 2 cardiovascular-kidney-metabolic syndrome (CKMS) access to healthy food through Instacart vouchers and food banks, plus nutrition counseling, is practical and engaging. Over 24 weeks, researchers measured how many peo…
Phase: NA • Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC